These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 33011283)
1. Clinical aspects of previously treated chromoblastomycosis: A case series from Madagascar. Sendrasoa FA; Razanakoto NH; Rakotoarisaona MF; Andrianarison M; Raharolahy O; Rasamoelina T; Ranaivo IM; Sata M; Ratovonjanahary V; Maubon D; Rakoto Andrianarivelo M; Cornet M; Ramarozatovo LS; Rapelanoro Rabenja F Int J Infect Dis; 2020 Dec; 101():228-232. PubMed ID: 33011283 [TBL] [Abstract][Full Text] [Related]
2. Treatment responses in patients with chromoblastomycosis to itraconazole in Madagascar. Sendrasoa FA; Ratovonjanahary VT; Rasamoelina T; Ramarozatovo LS; Rapelanoro Rabenja F Med Mycol; 2022 Nov; 60(11):. PubMed ID: 36288247 [TBL] [Abstract][Full Text] [Related]
3. Successful management of chromoblastomycosis utilizing conventional antifungal agents and imiquimod therapy. Zheng J; Liu S; Xie Z; Chen Y; Xi L; Liu H; Liu Y Ann Clin Microbiol Antimicrob; 2024 Jun; 23(1):57. PubMed ID: 38902740 [TBL] [Abstract][Full Text] [Related]
4. 5-aminolevulinic acid-based photodynamic therapy associated with Itraconazole successfully treated a case of chromoblastomycosis. Yang W; Zhang W; Luo J; Chen J; Tan Y; Lei X Photodiagnosis Photodyn Ther; 2020 Mar; 29():101589. PubMed ID: 31689509 [TBL] [Abstract][Full Text] [Related]
5. Nodular lesions of the buttock for 20 years: the challenge of chromoblastomycosis in non-endemic settings. Osborne W; Langman G; Ladoyanni E; Chue A BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38490708 [TBL] [Abstract][Full Text] [Related]
6. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil. Gupta AK; Taborda PR; Sanzovo AD Med Mycol; 2002 Oct; 40(5):529-34. PubMed ID: 12462534 [TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil. Guevara A; Nery AF; de Souza Carvalho Melhem M; Bonfietti L; Rodrigues AM; Hagen F; de Carvalho JA; de Camargo ZP; de Souza Lima BJF; Vicente VA; Hahn RC Mycoses; 2022 Dec; 65(12):1146-1158. PubMed ID: 35869803 [TBL] [Abstract][Full Text] [Related]
8. [Management of chromoblastomycosis, a challenge for limited-resource countries such as Madagascar]. Sendrasoa FA; Rakotoarisaona MF; Ranaivo IM; Razanakoto NH; Sata M; Raharolahy O; Andrianarison M; Ratovonjanahary V; Rasamoelina T; Rapelanoro Rabenja F; Ramarozatovo LS Ann Dermatol Venereol; 2020 May; 147(5):377-382. PubMed ID: 32220474 [TBL] [Abstract][Full Text] [Related]
9. [Natural history of chromoblastomycosis in Madagascar and the Indian Ocean] [Natural history of chromoblastomycosis in Madagascar and the [Natural history of chromoblastomycosis in Madagascar and the Indian Ocean]. Esterre P; Andriantsimahavandy A; Raharisolo C Bull Soc Pathol Exot; 1997; 90(5):312-7. PubMed ID: 9507759 [TBL] [Abstract][Full Text] [Related]
10. Chromoblastomycosis. Torres-Guerrero E; Isa-Isa R; Isa M; Arenas R Clin Dermatol; 2012; 30(4):403-8. PubMed ID: 22682188 [TBL] [Abstract][Full Text] [Related]
11. Auricular chromoblastomycosis caused by Rhinocladiella aquaspersa. Arango M; Jaramillo C; Cortés A; Restrepo A Med Mycol; 1998 Feb; 36(1):43-5. PubMed ID: 9776811 [TBL] [Abstract][Full Text] [Related]
12. Successful sequential treatment with itraconazole and ALA-PDT for chromoblastomycosis because of Alternaria alternata. Liu ZH; Xia XJ Dermatol Ther; 2014; 27(6):357-60. PubMed ID: 25039437 [TBL] [Abstract][Full Text] [Related]
13. Chromoblastomycosis: clinical experience and review of literature. Queiróz AJR; Pereira Domingos F; Antônio JR Int J Dermatol; 2018 Nov; 57(11):1351-1355. PubMed ID: 30113072 [TBL] [Abstract][Full Text] [Related]
14. Chromoblastomycosis in India: Review of 169 cases. Agarwal R; Singh G; Ghosh A; Verma KK; Pandey M; Xess I PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005534. PubMed ID: 28771470 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China. Zhang J; Xi L; Lu C; Li X; Xie T; Zhang H; Xie Z; De Hoog S Mycoses; 2009 Mar; 52(2):176-81. PubMed ID: 18627476 [TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro. Hu Y; Qi X; Sun H; Lu Y; Hu Y; Chen X; Liu K; Yang Y; Mao Z; Wu Z; Zhou X PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007849. PubMed ID: 31671098 [TBL] [Abstract][Full Text] [Related]
18. Retinoid combined with photodynamic therapy against hyperkeratotic chromoblastomycosis: A case report and literature review. Lan Y; Lu S; Zhang J Mycoses; 2021 Jan; 64(1):18-23. PubMed ID: 32989774 [TBL] [Abstract][Full Text] [Related]
19. Clinical improvement of chromoblastomycosis refractory to itraconazole successfully treated with high dose of terbinafine. Silva-Rocha WP; Cardoso FJ; Colalto W; Melo AS; Chaves GM J Dermatol; 2013 Sep; 40(9):775-6. PubMed ID: 23865635 [No Abstract] [Full Text] [Related]
20. Case Report: Successful Treatment of Chromoblastomycosis Caused by Bao F; Wang Q; Yu C; Shang P; Sun L; Zhou G; Wu M; Zhang F Am J Trop Med Hyg; 2018 Jul; 99(1):124-126. PubMed ID: 29785921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]